Autopsy report · NCT05300022

Technology Knowledge Optimization in Type 1 Diabetes (TeKnO T1D): Parents

“Investigator left the institution and is relinquishing the award supporting this study. The study will not launch.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Children's Hospital of Philadelphia

Sponsor type

University, hospital or other

Conditions

Type 1 Diabetes

Interventions

TeKnO T1D: Parents

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Residual Extensor Lag Approximately 1 Month After Splint or Cast Immobilization of a Mallet Finger
  “Due to the investigator leaving the institution, the study was terminated” (78% match in meaning)
• ACP for Local Application in Ankle Arthrodesis
  “Study was terminated due to the untimely death of the investigator” (75% match in meaning)
• Therapeutic Exercise in Patients With Hemophilia
  “The Study was terminated due to lack of funding for continuing” (75% match in meaning)
• Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer
  “The study was terminated due to futility and lack of future funding” (74% match in meaning)
• Heat-not-burn Tobacco Product to Aid in Switching From Combustible to Noncombustible Nicotine (IQOS)
  “Investigator left institution and did not retain the study” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.